ArticlePilot and feasibility studies2023

Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19.

Mohammad Ahmadvand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.